John Minni, Robert Sarro. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Erythema/drug therapyErythema/pathologyEtanerceptHumansImmunoglobulin G/administration & dosageImmunoglobulin G/therapeutic useImmunosuppressive Agents/administration & dosageImmunosuppressive Agents/therapeutic useMaleMiddle AgedReceptors, Tumor Necrosis Factor/administration & dosageReceptors, Tumor Necrosis Factor/antagonists & inhibitorsReceptors, Tumor Necrosis Factor/therapeutic useRetreatment
Substances： See more » Immunoglobulin GImmunosuppressive AgentsReceptors, Tumor Necrosis FactorEtanercept
Year: 2006 PMID： 16488327 DOI： 10.1016/j.jaad.2005.11.1044
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527